Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel
Type 2 diabetes mellitus (T2DM) is a progressive disease with multifactorial etiology. The first-line therapy includes monotherapy (with metformin), which often fails to provide effective glycemic control, necessitating the addition of add-on therapy. In this regard, multiple single-dose agents form...
Main Authors: | Sanjay Kalra, A K Das, G Priya, S Ghosh, R N Mehrotra, S Das, P Shah, S Bajaj, V Deshmukh, D Sanyal, S Chandrasekaran, D Khandelwal, A Joshi, T Nair, F Eliana, H Permana, M D Fariduddin, P K Shrestha, D Shrestha, S Kahandawa, M Sumanathilaka, A Shaheed, A A Rahim, A Orabi, A Al-ani, W Hussein, D Kumar, K Shaikh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=11;spage=5450;epage=5457;aulast=Kalra |
Similar Items
-
Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel
by: S. Kalra, et al.
Published: (2020-01-01) -
Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
by: Zimo Zhao, et al.
Published: (2023-07-01) -
Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action
by: Graziella Bruno, et al.
Published: (2010-09-01) -
Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis
by: Shuyan Gu, et al.
Published: (2022-11-01) -
Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
by: Mariusz Dąbrowski
Published: (2021-02-01)